Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201211010 Principal Investigator: Van Tine, Brian
Title: Phase 2 study of the mTOR inhibitor everolimus in combination with bevacizumab in patients with sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors
Phase: II Disease Site: Brain & Nervous System
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to determine how well malignant peripheral nerve sheath tumors respond (experience tumor shrinkage or lack of further tumor growth) to treatment with everolimus in combination with bevacizumab.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)